Document is current

Any future updates will be listed below

Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer

Crossref DOI link: https://doi.org/10.1186/s12885-016-2423-x

Published Online: 2016-07-07

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark